Health
Cutting edge synthetic peptides block SARS-CoV-2 (COVID-19) – News-Medical.Net
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to…
Researchers at Ligandal Inc., the University of California San Francisco and Toyota Technological Institute at Chicago, have designed novel synthetic peptides that potently inhibit the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to infect host cells.
The team’s SARS-BLOCK™ peptides competitively inhibit the receptor-binding domain (RBD) on the SARS-CoV-2 spike protein – the surface structure that binds the host cell angiotensin-converting enzyme 2 (ACE2) receptor, to…
-
Noosa News22 hours agoMan dies after stabbing in inner-city unit
-
General21 hours agoTwo British MPs refused entry into Israel, UK foreign ministry says
-
Noosa News21 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General15 hours agoTribute unveiled for SA Police Brevet Sergeant Jason Doig after fatal 2023 shooting